Literature DB >> 18674637

The vascular S1P gradient-cellular sources and biological significance.

Timothy Hla1, Krishnan Venkataraman, Jason Michaud.   

Abstract

Sphingosine 1-phosphate (S1P), a product of sphingomyelin metabolism, is enriched in the circulatory system whereas it is estimated to be much lower in interstitial fluids of tissues. This concentration gradient, termed the vascular S1P gradient appears to form as a result of substrate availability and the action of metabolic enzymes. S1P levels in blood and lymph are estimated to be in the muM range. In the immune system, the S1P gradient is needed as a spatial cue for lymphocyte and hematopoietic cell trafficking. During inflammatory reactions in which enhanced vascular permeability occurs, a burst of S1P becomes available to its receptors in the extravascular compartment, which likely contributes to the tissue reactions. Thus, the presence of the vascular S1P gradient is thought to contribute to physiological and pathological conditions. From an evolutionary perspective, S1P receptors may have co-evolved with the advent of a closed vascular system and the trafficking paradigms for hematopoietic cells to navigate in and out of the vascular system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18674637      PMCID: PMC2636563          DOI: 10.1016/j.bbalip.2008.07.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  91 in total

1.  The mouse gene for the inducible G-protein-coupled receptor edg-1.

Authors:  C H Liu; T Hla
Journal:  Genomics       Date:  1997-07-01       Impact factor: 5.736

2.  Sphingosine-1-phosphate mediates migration of mature dendritic cells.

Authors:  Niklas Czeloth; Günter Bernhardt; Fred Hofmann; Harald Genth; Reinhold Förster
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

3.  Sphingosine 1-phosphate-related metabolism in the blood vessel.

Authors:  Shinya Aoki; Yutaka Yatomi; Masato Ohta; Makoto Osada; Fuminori Kazama; Kaneo Satoh; Kazuhiko Nakahara; Yukio Ozaki
Journal:  J Biochem       Date:  2005-07       Impact factor: 3.387

4.  Cutting edge: regulation of T cell trafficking and primary immune responses by sphingosine 1-phosphate receptor 1.

Authors:  Hongbo Chi; Richard A Flavell
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

5.  Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum.

Authors:  Y Yatomi; Y Igarashi; L Yang; N Hisano; R Qi; N Asazuma; K Satoh; Y Ozaki; S Kume
Journal:  J Biochem       Date:  1997-05       Impact factor: 3.387

Review 6.  Genomic insights into mediator lipidomics.

Authors:  Timothy Hla
Journal:  Prostaglandins Other Lipid Mediat       Date:  2005-09       Impact factor: 3.072

7.  An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors.

Authors:  T Hla; T Maciag
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

8.  Immunological effects of transgenic constitutive expression of the type 1 sphingosine 1-phosphate receptor by mouse lymphocytes.

Authors:  Markus H Gräler; Mei-Chuan Huang; Susan Watson; Edward J Goetzl
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

9.  Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference.

Authors:  Sung-Suk Chae; Ji-Hye Paik; Henry Furneaux; Timothy Hla
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 10.  Physiological and pathological actions of sphingosine 1-phosphate.

Authors:  Timothy Hla
Journal:  Semin Cell Dev Biol       Date:  2004-10       Impact factor: 7.727

View more
  85 in total

Review 1.  Shaping the landscape: metabolic regulation of S1P gradients.

Authors:  Ana Olivera; Maria Laura Allende; Richard L Proia
Journal:  Biochim Biophys Acta       Date:  2012-06-23

Review 2.  Sphingosine-1-phosphate and immune regulation: trafficking and beyond.

Authors:  Hongbo Chi
Journal:  Trends Pharmacol Sci       Date:  2010-12-14       Impact factor: 14.819

Review 3.  Hematopoietic stem and progenitor cells: their mobilization and homing to bone marrow and peripheral tissue.

Authors:  Christian Schulz; Ulrich H von Andrian; Steffen Massberg
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

4.  Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein.

Authors:  Koichi Sato; Fumikazu Okajima
Journal:  World J Biol Chem       Date:  2010-11-26

Review 5.  Metabolomic and molecular insights into sickle cell disease and innovative therapies.

Authors:  Morayo G Adebiyi; Jeanne M Manalo; Yang Xia
Journal:  Blood Adv       Date:  2019-04-23

Review 6.  Vascular and Immunobiology of the Circulatory Sphingosine 1-Phosphate Gradient.

Authors:  Keisuke Yanagida; Timothy Hla
Journal:  Annu Rev Physiol       Date:  2016-10-21       Impact factor: 19.318

7.  Sphingosine 1-phosphate (S1P) receptors 1 and 2 coordinately induce mesenchymal cell migration through S1P activation of complementary kinase pathways.

Authors:  Patrick Quint; Ming Ruan; Larry Pederson; Moustapha Kassem; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  J Biol Chem       Date:  2013-01-07       Impact factor: 5.157

8.  Sphingosine 1-phosphate receptor signaling regulates proper embryonic vascular patterning.

Authors:  Karen Mendelson; Tomasz Zygmunt; Jesús Torres-Vázquez; Todd Evans; Timothy Hla
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

9.  Sphingosine-1-phosphate evokes unique segment-specific vasoconstriction of the renal microvasculature.

Authors:  Zhengrong Guan; Sean T Singletary; Anthony K Cook; Janet L Hobbs; Jennifer S Pollock; Edward W Inscho
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

Review 10.  Lysophosphatidic acid in vascular development and disease.

Authors:  Siew T Teo; Yun C Yung; Deron R Herr; Jerold Chun
Journal:  IUBMB Life       Date:  2009-08       Impact factor: 3.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.